Purdue to hold 5th annual International Breast Cancer Prevention Symposium in West Indies
September 28, 2015
WEST LAFAYETTE, Ind. - A global panel of breast cancer experts and researchers will meet in Le Gosier, Guadeloupe in the French West Indies this week for the fifth annual International Breast Cancer Prevention Symposium.
The Oct. 2-3 event is titled "Epigenome, Environment and Prevention Tools" and organized by the Purdue-led International Breast Cancer and Nutrition (IBCN) Group. This year's event will focus on global breast cancer prevention efforts with speakers from Russia, France, Korea, Taiwan, Germany and Uruguay.
Other topics will include "Environmental Medicine and the Epigenome," "Biomarkers for Prevention Intervention," "Local Nutrition Facing Globalization," "Interventions in Prevention," and "Gynecologic Cancers & Environmental Policy."
"This year's symposium will explore the impact of new knowledge in the genome on prevention interventions and cover leading research involving disciplines across the board - from the effects of nutrition and physical activity on prevention of this disease to the molecular mechanisms underlying cancer chemoprevention," said event co-organizer Sophie A. Lelièvre (pronounced Le-LEE-YEA-vre), a professor of basic medical sciences in Purdue's College of Veterinary Medicine and associate director of collaborative science for the Purdue Center for Cancer Research.
Working as co-chairs of the IBCN with Lelièvre are Connie Weaver, a distinguished Purdue professor and head of the Department of Nutrition Science; Martine Bellanger, a professor of health economics at the EHESP French School of Public Health; and Dr. Philippe Kadhel of the University Teaching Hospital in Pointe-A-Pitre, Guadeloupe.
Young-Joon Surh, professor of biochemistry at the Seoul National University College of Pharmacy in South Korea and director of the Tumor Microenvironment Global Core Research Center Research Center (GCRC), will deliver a keynote talk.
Surh has researched cancer chemoprevention targeting intracellular signaling network that is often deregulated in diseases such as cancer, and investigated the molecular mechanisms of cancer prevention with anti-inflammatory and antioxidative phytochemicals.
Weaver said the event's goal is to highlight the interdisciplinary nature of breast cancer research and how the perspectives of experts in diverse fields from different countries is critical to address this major global health challenge.
"By bringing together public health experts and researchers in breast cancer prevention with the brightest minds in all involved business and research sectors, we can highlight those advancements that we deem not only possible but necessary," Weaver said.
Full registration cost is $325, excluding lodging and transportation costs, while registration for students, advocates and IBCN members is $150. For more information or to register, contact Kris Swank at email@example.com or 765-494-4674.
Lead Purdue sponsors are the Oncological Sciences Center in Discovery Park, Purdue Center for Cancer Research, Department of Nutrition Science, Susan Bulkeley Butler Institute for the Development of Women Leaders and the Office of the Provost.
External supporters and sponsors are the Departmental Council of Guadeloupe, National Institute for Prevention and Health Education (INPES) at the EHESP School of Public Health, the EHESP School of Public Health, Ipsen, Roche, Novartis, Sepropharm, Amgen, GKS, Janssen, Jumbo Car Guadeloupe, Sanofi Pasteur, and Bayer.
The IBCN, involving the World Health Organization and the International Agency for Research on Cancer, is focusing initial efforts in the United States and Ghana, as well as France, Uruguay and Lebanon. Since the inaugural event in 2010, the IBCN has hosted annual conferences in France, Uruguay, Lebanon and, most recently, West Lafayette.
Writers: Phillip Fiorini, 765-496-3133, firstname.lastname@example.org
Anna Schultz, 765-494-4719, email@example.com
Sources: Sophie Lelièvre, 765-496-7793, firstname.lastname@example.org
Connie Weaver, 765-494-8237, email@example.com